Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
No Moni study
NL-OMON20049Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2018
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of Sugammadex and rocuronium, sponsored by Leiden University Medical Center. Primary endpoint: Time to complete recovery of neuromuscular function after sugammadex administration. Started Sep 2018; status: active, not recruiting.
02
Drugs
Sugammadexrocuronium
Beyond the preview
Go deeper on NL-OMON20049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20049.